Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EM Industries, Inc. was the historical North American operating subsidiary of Merck KGaA, Darmstadt, Germany. The company served as a primary vehicle for Merck KGaA's chemical and pharmaceutical interests in the United States and Canada, where it operated under the EMD brand to avoid confusion with Merck & Co. Over time, EM Industries was restructured and rebranded into specialized divisions such as EMD Serono, EMD Millipore, and EMD Electronics. Today, the legacy of EM Industries is integrated into Merck KGaA's global operations, which focus on innovative treatments in oncology, neurology, and immunology. The company also maintains a significant presence in the life science tools and electronics sectors. Its current pharmaceutical pipeline includes advanced therapies for various cancers and autoimmune diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EM Industries.